KRRO - NASDAQ

Korro Bio, Inc.

Korro Bio, Inc.

KRRO·NASDAQ

$11.08

+2.1%
HealthcareBiotechnology

Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts.

StatementsValue Model

At a Glance

Live Snapshot
Market Cap$110.28M
EPS-12.4800
P/E Ratio-0.89
Earnings Date08/11/2026

Available Earnings Call Transcripts

Select a year and quarter to view the full transcript.

Korro Bio, Inc.

Korro Bio, Inc. Earnings Call Transcripts

KRRO · NASDAQ

No Transcripts Available

No earnings call transcripts found for krro.

Related Guides

Blog Categories

Continue your KRRO research with focused valuation guides.

Forecasting

Compare management guidance with modeled outcomes.

Risk Analysis

Track estimate risk, misses, and downside scenarios.

Reference

Review analyst process and transcript interpretation.

Value Investing

Anchor quarterly narrative to intrinsic value discipline.

Research Paths

Pick your next lens
1

Snapshot

Start with context, operating signals, and key market metrics.

2

Value Model

Stress test fair value across bear, base, and bull assumptions.

3

Statements

Validate revenue quality, margins, and balance sheet durability.

4

Earnings Call

Read management commentary and compare it with reported outcomes.

5

Dividends

Check payout sustainability and long-term distribution behavior.

6

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.